Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127723401 | 12772340 | 1 | I | 20160921 | 20160922 | 20160922 | PER | US-GLAXOSMITHKLINE-US2016138564 | GLAXOSMITHKLINE | 77.00 | YR | F | Y | 0.00000 | 20160922 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127723401 | 12772340 | 1 | PS | NICODERM CQ | NICOTINE | 1 | UNK | Y | UNK | 20165 | TRANSDERMAL PATCH | ||||||||
| 127723401 | 12772340 | 2 | SS | NICODERM CQ | NICOTINE | 1 | 14 MG, UNK | Y | 1512715 | 20165 | 14 | MG | TRANSDERMAL PATCH | ||||||
| 127723401 | 12772340 | 3 | C | Atorvastatin | ATORVASTATIN | 1 | UNK | U | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127723401 | 12772340 | 1 | Smoking cessation therapy |
| 127723401 | 12772340 | 2 | Smoking cessation therapy |
| 127723401 | 12772340 | 3 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127723401 | 12772340 | Application site pruritus | |
| 127723401 | 12772340 | Application site reaction |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127723401 | 12772340 | 2 | 201609 | 201609 | 0 |